Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | ARGX | BNTX | ||
| Company | Alnylam Pharmaceuticals | Argenx Se ADR | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 242.70 | 626.20 | 115.35 | ||
| High | 249.58 | 644.97 | 118.98 | ||
| Low | 240.42 | 621.75 | 114.48 | ||
| Last | 246.58 | 638.33 | 117.39 | ||
| Change | +2.59 | +5.69 | +3.17 | ||
| % Change | +1.06% | +0.90% | +2.78% | ||
| Volume | 634,400 | 459,600 | 655,600 | ||
| 20-Day Average Volume | 641,125 | 302,625 | 822,905 | ||
| Previous Close | 243.99 | 632.64 | 114.22 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 249.94 | 610.97 | 116.30 | ||
| 20-Day Raw Stochastic | 57.08% | 92.36% | 67.15% | ||
| 20-Day Relative Strength | 42.21% | 64.77% | 52.99% | ||
| Weighted Alpha | +8.34 | +80.08 | +3.68 | ||
| Today's Opinion | 8% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 80% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.89% since 12/10/24 | +4.66% since 12/10/24 | +0.46% since 12/10/24 | ||
| Low | 240.42 on 12/17/24 | 602.44 on 12/13/24 | 112.91 on 12/16/24 | ||
| High | 255.92 on 12/11/24 | 644.97 on 12/17/24 | 123.30 on 12/12/24 | ||
| 1-Month | |||||
| %Chg | +4.68% since 11/15/24 | +13.13% since 11/15/24 | +17.72% since 11/15/24 | ||
| Low | 229.85 on 11/18/24 | 558.15 on 11/19/24 | 98.25 on 11/18/24 | ||
| High | 258.12 on 12/09/24 | 644.97 on 12/17/24 | 125.40 on 12/06/24 | ||
| 3-Month | |||||
| %Chg | -10.16% since 09/17/24 | +22.23% since 09/17/24 | -5.87% since 09/17/24 | ||
| Low | 229.85 on 11/18/24 | 512.01 on 09/24/24 | 94.31 on 11/15/24 | ||
| High | 304.39 on 10/17/24 | 644.97 on 12/17/24 | 125.40 on 12/06/24 | ||
| 6-Month | |||||
| %Chg | +56.76% since 06/17/24 | +68.74% since 06/17/24 | +32.73% since 06/17/24 | ||
| Low | 152.30 on 06/18/24 | 377.48 on 06/18/24 | 76.53 on 08/05/24 | ||
| High | 304.39 on 10/17/24 | 644.97 on 12/17/24 | 131.49 on 09/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,804,136 | 38,534,708 | 27,906,652 | ||
| Shares Outstanding, K | 128,981 | 60,368 | 237,726 | ||
| Annual Sales | 1,828,290,000 | 1,268,590,000 | 4,133,300,000 | ||
| Annual Net Income | -440,240,000 | -295,050,000 | 1,006,860,000 | ||
| Last Quarter Sales | 500,920,000 | 588,880,000 | 1,368,780,000 | ||
| Last Quarter Net Income | -111,570,000 | 91,410,000 | 217,830,000 | ||
| 60-Month Beta | 0.32 | 0.59 | 0.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 10/31/24 | 1.39 on 10/31/24 | 0.89 on 11/04/24 | ||
| Latest Earnings Date | 10/31/24 | 10/31/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | N/A | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||